已收盤 07-18 16:00:00 美东时间
-0.160
-1.04%
Brandywine Operating Partnership, L.P., a subsidiary of Brandywine Realty Trust, has closed an underwritten public offering of $150 million of its 8.875% guaranteed notes due 2029 with a re-offer yield of 7.039%. These Notes are part of the same series as the $400 million notes issued in April 2024. Proceeds will be used to repay borrowings under the company's $600 million credit facility, fund partial repayment of secured debt, and for general c...
06-27 16:13
BRT Apartments Corp. (NYSE: BRT) announced a quarterly dividend of $0.25 per share, payable on July 9, 2025, to stockholders of record as of June 25, 2025. The company, a real estate investment trust, owns or has interests in 29 multi-family properties with 7,947 units across 11 states. For more information, visit www.brtapartments.com or contact BRT at investors@BRTapartments.com.
06-04 20:15
On June 4, 2025, Brandywine Realty Trust executives Jerry Sweeney (CEO), Tom Wirth (CFO), and Dan Palazzo will present at Nareit’s REITweek 2025 conference. The 30-minute analyst-led roundtable starts at 2:00 p.m. ET and can be accessed live via webcast at the provided link. A replay will be available on Brandywine’s website until June 13.
05-30 13:00
Real estate markets are still not getting a lot of love from the investing worl...
05-29 23:17
BRT Apartments (NYSE:BRT) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.27 by 44.44 percent. This is a 11.43 percent increase over earnings of $0.35 per share from the
05-09 05:15
US homebuyers and refinancers took advantage of lower rates ahead of Fed's policy decision. Mortgage applications rose 11%, signaling housing market revival.
05-07 20:24
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112661771769712640.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer:维持Sensei Biotherapeutics(SNSE)"跑赢大市"评级,目标价从3.5美元升至4美元</p> <p>• 富国银行:上调Regulus Therapeutics(RGLS)评级至
03-29 18:13
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1112300378952404993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer:维持Corvus Pharma(CRVS)"跑赢大市"评级,目标价从14美元升至15美元</p> <p>• 富国银行:上调Regulus Therapeutics(RGLS)评级至"超配",目标价从
03-28 09:06
With U.S. stock futures trading mixed this morning on Monday, some of the stock...
2024-08-12 15:32
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.
2024-03-25 21:00